Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer

BackgroundThis study aimed at assessing the safety and immunogenicity of SARS-CoV-2 vaccines in patients with thyroid cancer.MethodsThis observational study included thyroid cancer patients between April 1, 2021, and November 31, 2021, in the Second Affiliated Hospital of Chongqing Medical Universit...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yuling Han, Jiaxin Yang, Danshuang He, Yang Feng, Xiaoman Liu, Yu Min, Shenghao Fan, Guobing Yin, Daixing Hu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2022-05-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	Coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inactivated SARS-CoV-2 vaccine immunogenicity safety
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.855311/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!